| Factor Information | |
|---|---|
| Data ID | 3099 |
| Factor | systolic blood pressure(SBP) across the stenosis (mm Hg) |
| Description | N/A |
| Biomarker | NA |
| Classification | E9 (physiological factor - hemodynamic parameter) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | the aim of this study was to evaluate the immediate, early, and intermediaate-term results of CP stent implantation in the treatment of vessel stenosis associated with CHD in children and adolescents |
| p Value | <0.01 |
| Conclusion | CP stent implantation is safe and feasible for the treatment of vessel stenosis associated with CHD in children and adolescents. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 650 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF/PA, IVS, PDA, ASD/CoA |
| Reference | |
|---|---|
| PMID | 19555561 |
| Year | 2009 |
| Title | Therapeutic effect of Cheatham-Platinum stent implantafion for vessel stenosis associated with congenital heart disease in children and adolescent. |
| Sample | ||
|---|---|---|
| Population | children and adolescent | |
| Source | patients' data | |
| Region | Shanghai, China | |
| Method | t test | |
| Race | Chinese | |
| Disease History | N/A | |
| Treatment History | surgery | |
| Group | vascular stenosis associated with CHD before CP stent implantation(Treatment) | vascular stenosis associated with CHD after CP stent implantation(Control) |
| Number | 5 | 5 |
| Age | average=10.8, median=12 | average=10.8, median=12 |
| Gender (Male: Female) | 03:02:00.000 | 03:02:00.000 |
| Marker Level | 43.43±25.61 | 3.29±3.09 |
